TargeGen
TargeGen, Inc., a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target vascular leakage (edema), vascular proliferation (angiogenesis), and inflammation. The company offers its...Founded in 2002
Homepage: http://www.targegen.com/
92121
9380 Judicial Drive
San Diego
USA CA
San Diego
USA CA
Phone: 858-678-0760
Updated on Aug 12, 2011
TargeGen at CrunchBase
Wood C. Erwin CFOTargeGen at CrunchBase
Past
Peter G. Ulrich Co-Founder, President & CEO
June, 2010
TargeGen was acquired by Sanofi Aventis
for $635M
On a spree, Sanofi scoops up TargeGen in $635M dea Read more: On a spree, Sanofi scoops up TargeGen in $635M deal 
fiercebiotech.com
2002
TargeGen was founded in 2002